Effects of the Japanese herbal medicine 'Sho-saiko-to' (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C

Hepatology

Volumn 25, Issue 6, 1997, Pages 1390-1397

  Yamashiki, Masayoshi ^a   Nishimura, Akira ^b   Suzuki, Hiroyuki ^c   Sakaguchi, Seigo ^d   Kosaka, Yoshitane ^a  

^a MIE UNIVERSITY   (Japan)

^b SUZUKA GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF MARYLAND   (United States)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; HERBACEOUS AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; OKT 3; PACLITAXEL; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; SCUTELLARIAE RADIX; XIAO CHAI HU TANG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; GLYCYRRHIZA; HEPATITIS B; HEPATITIS C; HERBAL MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CANCER; MACROBIOTIC DIET; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; CHRONIC DISEASE; CONCANAVALIN A; CYTOKINES; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS C; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; TIME FACTORS;

EID: 0030902782     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250615     Document Type: Article

References (10)

1. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggener JG, et al. Treatment of chronic non-A non-B hepatitis with recombinant human alpha interferon: a multicenter randomized, controlled trial. N Engl J Med 1986;315:1575-1578.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr. HC, Perrillo RP, Galey W, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: multicenter randomized, controlled trial. N Engl J Med 1989:321:1501-1506.
3. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. HEPATOLOGY 1991; 13:1040-1043.
4. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. HEPATOLOGY 1992;15:1013-1016.
5. Yamamoto M, Uemura T, Nakama S, Uemiya M, Kasayama S, Kishida Y, Yamauchi K, et al. A fundamental study of chronic hepatitis treated with saiko agents. Proceedings of the Symposium of Wakan-Yaku 1983;16:245-248.
6. Oka H, Fujiwara K, Oda T. Xiano-Chai-Hu-Tang and Gui-Zhi-Fu-Ling-Wan for treatment of chronic hepatitis. In: Oda T, Needham J, Otsuka Y, Guo-bin L, eds. Recent Advances in Traditional Medicine in the East Asia. Amsterdam: Excerpta Medica, 1984:232-237.
7. Fujiwara K, Ohta Y, Ogata I, Hayashi S, Sato Y, Oka Y, Yamada S, et al. Treatment trial of traditional Oriental medicine in chronic viral hepatitis. In: Ota Y, ed. New Trends in Peptic Ulcer and Chronic Hepatitis: Part II. Chronic Hepatitis. Tokyo: Excerpta Medica, 1987:141-146.
8. Tajiri H, Kozaiwa K, Osaki Y, Hamamoto T, Miki K, Shimizu K, Ida S, et al. The study of the effect of Sho-saiko-to on HBeAg clearance in children with chronic HBV infection and with abnormal liver function test results. Acta Paediatr Jpn 1990;94:1811-1815.
9. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, et al. Prospective study of chemotherapy of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995;76:743-749.
10. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994;54:448-454.